Typhoid Vi Polysaccharide Vaccine Market Size and Forecast 2023-2032|Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc.,

The Typhoid Vi Polysaccharide Vaccine Global Market Report 2023, provides comprehensive information on the typhoid vi polysaccharide vaccine market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Typhoid Vi Polysaccharide Vaccine Market’s Growth:

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

The global typhoid Vi polysaccharide vaccine market size is expected to grow from $4.23 billion in 2022 to $4.96 billion in 2023 at a compound annual growth rate (CAGR) of 17.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the typhoid Vi polysaccharide vaccine market is expected to grow to $9.20 billion in 2027 at a CAGR of 16.7%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=8313&type=smp

Strategic partnerships are a key trend gaining popularity in the typhoid Vi polysaccharide vaccine market. Major companies operating in the typhoid Vi polysaccharide vaccine market are entering into partnerships to strengthen their position in the typhoid Vi polysaccharide market. For instance, in July 2022, The International Vaccine Institute, a South Korea-based international organization focused on infectious diseases of global health importance such as cholera, typhoid, shigella, and salmonella, partnered with Moderna, a US-based biopharmaceutical company. This partnership led to the world’s first affordable oral cholera vaccine and a new-generation typhoid conjugate vaccine. Further, in December 2020, Biological E, an India-based biotechnology and biopharmaceutical company, collaborated with the GSK Vaccines Institute for Global Health (GVGH), a UK-based research and development center operating in the typhoid Vi polysaccharide vaccine. This collaboration is for the development of a typhoid conjugate vaccine (TCV)

The typhoid vi polysaccharide vaccine market is segmented:

1) By Type: Child, Adult

2) By Route of Administration: Oral, Parenteral

3) By Application: Government Institutions, Private Sector, Other Applications

Asia-Pacific was the largest region in the typhoid vi polysaccharide vaccine market in 2022.

1. Executive Summary

2. Typhoid Vi Polysaccharide Vaccine Market Characteristics

3. Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies

4. Typhoid Vi Polysaccharide Vaccine Market – Macro Economic Scenario

5. Typhoid Vi Polysaccharide Vaccine Market Size And Growth

.

.

.

26. Africa Typhoid Vi Polysaccharide Vaccine Market

27. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Typhoid Vi Polysaccharide Vaccine Market

29. Typhoid Vi Polysaccharide Vaccine Market Future Outlook and Potential Analysis

30. Appendix

 Top Major Players:

• Sanofi Pasteur SA
• GlaxoSmithKline plc
• Merck & Co. Inc
• Pfizer Inc
• AstraZeneca plc

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model